Core Biogenesis
Core Biogenesis fights against cancer and neurodegenerative diseases
Core Biogenesis has raised €20M across 2 funding rounds from 5 investors, most recently a Series A round in Jul 2022. Based in Strasbourg, France; active in Healthtech. Data as of 28 Oct 2026.
Strasbourg, Francecorebiogenesis.com ↗
Total raised
€20M
€20,296,136
Funding rounds
2
Investors
5
distinct backers
Active since
2022-03
latest 2022-07
Funding by year
EUR raised per yearCore Biogenesis — funding by year — interactive chart.
Data table
| Core Biogenesis — funding by year | |
|---|---|
| 2022 | €20M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-07-29 | Series A | €10M | Blue Horizon Ventures,Thia Ventures,XAnge | View deal → |
| 2022-03-29 | Other | €10M | Angel Investors,Blue Horizon Ventures,Entrepreneur First,Thia Ventures,XAnge | View deal → |
Investors
5Related news
- Core Biogenesis Raises $10.5M in Series A Fundingfinsmes.com · 2022-07
- [Série A] Core Biogenesis lève 10 millions d’euros auprès de XAnge et Blue Horizonfrenchweb.fr · 2022-03
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData